A new treatment for the asbestos-related disease, mesothelioma, is offering a ray of hope to victims of the deadly cancer, researchers say.
The Asbestos Diseases Research Institute in Sydney has published the results of laboratory testing of a novel genetic treatment in the international Journal Oncology.
The treatment uses bacterial mini cells which have no genetic information to carry messenger cells, or micro RNA, into mesothelioma tumours.
The mini cells are protected with a coating of anti-bodies that protect them on the way to the target.
Scientists say it appears to be halting the growth of cancer in animals.